No abstract available
Keywords:
cancer; checkpoint inhibitors; immunotherapy; pembrolizumab; rare; sarcoma.
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Humans
-
Immune Checkpoint Inhibitors / therapeutic use*
-
Immunotherapy
-
Rare Diseases
-
Sarcoma / classification
-
Sarcoma / drug therapy*
-
Soft Tissue Neoplasms / classification
-
Soft Tissue Neoplasms / drug therapy*
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Immune Checkpoint Inhibitors
-
pembrolizumab